217 related articles for article (PubMed ID: 787517)
1. Defence systems of the body, immunosuppression and immunotherapy.
James DG
J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
[No Abstract] [Full Text] [Related]
2. Immunotherapy of human cancer.
Hersh EM; Gutterman JU; Mavligit GM
Adv Intern Med; 1977; 22():145-85. PubMed ID: 65906
[No Abstract] [Full Text] [Related]
3. [Immunotherapy today].
D'Amelio R
Riv Med Aeronaut Spaz; 1977; 40(1-2):123-52. PubMed ID: 311930
[No Abstract] [Full Text] [Related]
4. Immunotherapy.
James DG
Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(4):468-73. PubMed ID: 364779
[No Abstract] [Full Text] [Related]
5. [Advances in rheumatology. Immunostimulation in rheumatoid diseases].
Plachecka-Gutowska M
Pol Arch Med Wewn; 1975 May; 53(5):491-9. PubMed ID: 1094431
[No Abstract] [Full Text] [Related]
6. Immunologic aspects of malignant tumors.
Ariyan S
Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
[No Abstract] [Full Text] [Related]
7. [Current concepts of the growth mechanisms of the immune response].
Voĭtenok NN
Ter Arkh; 1980; 52(9):132-40. PubMed ID: 6449091
[No Abstract] [Full Text] [Related]
8. [Immunotherapy of tuberculosis (literature review)].
Averbakh MM; Litvinov VI
Probl Tuberk; 1976 Apr; (4):65-70. PubMed ID: 824645
[No Abstract] [Full Text] [Related]
9. Non-specific and adaptive immunity in renal transplantation.
Alexander JW; McCoy HV; Phair JP; Altemeier WA
Transplant Proc; 1969 Mar; 1(1):283-6. PubMed ID: 4944227
[No Abstract] [Full Text] [Related]
10. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
11. [Immunosuppressive therapy].
Miescher PA; Graf JH
Ther Umsch; 1979 May; 36(5):385-90. PubMed ID: 313085
[No Abstract] [Full Text] [Related]
12. Immunology of malignancy.
Kaufman JR
J Indiana State Med Assoc; 1975 Aug; 68(8):712-5. PubMed ID: 1095658
[No Abstract] [Full Text] [Related]
13. Histocompatibility determinants, immune responsiveness and aging in man.
Greenberg LJ; Yunis EJ
Fed Proc; 1978 Apr; 37(5):1258-62. PubMed ID: 305855
[No Abstract] [Full Text] [Related]
14. The role of cellular immunity in neoplasia.
Glade PR; Zaldivar NM; Mayer L; Cahill LT
Pediatr Res; 1976 May; 10(5):517-22. PubMed ID: 778771
[No Abstract] [Full Text] [Related]
15. Immunotherapy: new hope for the cancer patient.
Costanzi JJ; Goldstein AL
Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856
[No Abstract] [Full Text] [Related]
16. [Effect of immunodepressive and immunostimulating therapy on the indices of the T and B immunity systems in collagen diseases].
Gandzha IM; Sakharchuk VM
Vrach Delo; 1979 Jun; (6):20-3. PubMed ID: 314199
[No Abstract] [Full Text] [Related]
17. Immunotherapy of autoimmune disease with T cell subset specific antibodies.
Sriram S; Ranges GE
Concepts Immunopathol; 1987; 4():275-86. PubMed ID: 3297338
[No Abstract] [Full Text] [Related]
18. HLA-B7 associated tuberculin hyporesponsiveness in BCG treated melanoma patients.
Buckley CE; White DH; Seigler HF
Monogr Allergy; 1977; 11():97-105. PubMed ID: 876133
[TBL] [Abstract][Full Text] [Related]
19. [Immunology of tumors: correlation between immunological competence, clinical evolution and therapeutic response].
Kopersztych S; Naspitz CK; Mendes NF
Rev Hosp Clin Fac Med Sao Paulo; 1975; 30(6):513-6. PubMed ID: 1108153
[No Abstract] [Full Text] [Related]
20. The immune response and cancer. A guide.
Gilbert HA; Kagan AR
Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
